Bill
Bill > HB1319
MD HB1319
MD HB1319Health Insurance - Lyme Disease and Related Tick-Borne Illnesses - Long-Term Antibiotic Treatment
summary
Introduced
02/08/2021
02/08/2021
In Committee
02/08/2021
02/08/2021
Crossed Over
Passed
Dead
04/12/2021
04/12/2021
Introduced Session
2021 Regular Session
Bill Summary
Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide coverage for certain long-term antibiotic treatment of Lyme disease and related tick-borne illnesses under certain circumstances; prohibiting an entity subject to the Act from denying certain treatment under certain circumstances; providing that the Act applies to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after January 1, 2022; etc.
AI Summary
This bill requires certain insurers, nonprofit health service plans, and health maintenance organizations in Maryland to provide coverage for long-term antibiotic treatment of Lyme disease and related tick-borne illnesses when ordered by a licensed treating physician for therapeutic purposes. The bill defines key terms like "Lyme disease," "long-term antibiotic therapy," and "related tick-borne illness." It prohibits these entities from denying coverage solely because the treatment may be considered unproven, experimental, or investigational. The bill applies to all policies, contracts, and health benefit plans issued, delivered, or renewed in the state on or after January 1, 2022.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Hearing 3/11 at 1:30 p.m. (on 02/11/2021)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1319?ys=2021RS |
| BillText | http://mgaleg.maryland.gov/2021RS/bills/hb/hb1319f.pdf |
Loading...